|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.50 GBX | +0.83% |
|
+17.48% | +4.31% |
| 04/02 | Avacta Therapeutics Announces Two Key Clinical Updates to its Faridoxorubicin Clinical Program | CI |
| 03/02 | Avacta reports progress in faridoxorubicin clinical programme | AN |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -8.81x | - | 0.16x | 41.47x | -10.77x | -9.19x | -.--% | 36Cr | |
| 46.3x | 7.32x | 2.07x | 11.03x | 39.37x | 40.39x | 0.02% | 5.03TCr | |
| 16.91x | 4.05x | 0.22x | 6.04x | 13.29x | 14.51x | 1.77% | 4.21TCr | |
| -25.72x | 75.02x | -5.57x | 51.77x | -29.4x | -27.74x | -.--% | 3.2TCr | |
| -26.38x | 1.21x | -1.12x | 4.43x | -12.22x | -9.64x | -.--% | 2.68TCr | |
| 30.86x | 2.86x | 0.79x | 6.1x | 16.89x | 21.03x | -.--% | 1.99TCr | |
| 16.61x | 3.19x | -5.82x | 3.9x | 10.31x | 10.91x | -.--% | 1.91TCr | |
| -175.88x | 22.09x | -2.02x | 43.39x | -175.79x | -155.67x | -.--% | 1.26TCr | |
| -306.26x | 10.49x | 5.98x | 24.05x | 1011.94x | -306.64x | -.--% | 1.19TCr | |
| 16.6x | 4.52x | 0.33x | 4.78x | 11.62x | 12.87x | -.--% | 1.18TCr | |
| -11.37x | - | -0.04x | 142.01x | -22.14x | -11.14x | -.--% | 1.16TCr | |
| -44.57x | 19.12x | 0.87x | 10.89x | -37.86x | -40.57x | -.--% | 1.08TCr | |
| -19.29x | 16.8x | -0x | 17x | -28.06x | -20.01x | -.--% | 903.49Cr | |
| 52.45x | 8.37x | 0.73x | 15.94x | 47.92x | 51.78x | 0.18% | 845.08Cr | |
| -10.12x | - | -0.22x | - | -9.32x | -8.87x | -.--% | 806.07Cr | |
| -18.1x | 7.8x | -0.4x | - | -18.6x | -17.97x | -.--% | 804.45Cr | |
| Average | -29.17x | 14.07x | -0.25x | 27.34x | 50.45x | -28.50x | 0.12% | 1.77TCr | |
| Weighted average by Cap. | -13.43x | 15.36x | -0.46x | 21.49x | 38.95x | -13.67x | 0.27% |
- Stock Market
- Equities
- AVCT Stock
- Sector Avacta Group Plc
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition